,date,title,url
0,2014-10-15,九洲药业关于股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2014-10-14/603456_20141015_1.pdf
1,2014-10-17,九洲药业关于股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2014-10-16/603456_20141017_1.pdf
2,2014-10-18,九洲药业关于使用补充流动资金的公告,/disclosure/listedinfo/announcement/c/2014-10-17/603456_20141018_1.pdf
3,2014-10-23,九洲药业关于使用募集资金置换预先已投入募投项目的自筹资金的公告,/disclosure/listedinfo/announcement/c/2014-10-22/603456_20141023_3.pdf
4,2014-10-23,九洲药业独立董事关于使用募集资金置换预先己投入募投顼目的自筹资金的独立意见,/disclosure/listedinfo/announcement/c/2014-10-22/603456_20141023_6.pdf
5,2014-10-23,九洲药业第四届监事会第八次会议决议公告,/disclosure/listedinfo/announcement/c/2014-10-22/603456_20141023_4.pdf
6,2014-10-23,九洲药业第四届董事会第十八次会议决议公告,/disclosure/listedinfo/announcement/c/2014-10-22/603456_20141023_2.pdf
7,2014-10-23,九洲药业第三季度季报,/disclosure/listedinfo/announcement/c/2014-10-22/603456_2014_3.pdf
8,2014-10-23,九洲药业：招商证券股份有限公司关于浙江九洲药业股份有限公司使用募集资金置换预先投入募投项目自筹资金的专项核查意见,/disclosure/listedinfo/announcement/c/2014-10-22/603456_20141023_7.pdf
9,2014-10-23,九洲药业：关于公司以自筹资金预先投入募投项目的鉴证报告,/disclosure/listedinfo/announcement/c/2014-10-22/603456_20141023_8.pdf
10,2014-11-01,九洲药业修订公司章程并办理相应工商变更登记的公告,/disclosure/listedinfo/announcement/c/2014-10-31/603456_20141101_3.pdf
11,2014-11-01,九洲药业投资者关系管理制度,/disclosure/listedinfo/announcement/c/2014-10-31/603456_20141101_12.pdf
12,2014-11-01,九洲药业募集资金管理制度,/disclosure/listedinfo/announcement/c/2014-10-31/603456_20141101_11.pdf
13,2014-11-01,九洲药业会计政策变更的公告,/disclosure/listedinfo/announcement/c/2014-10-31/603456_20141101_5.pdf
14,2014-11-01,九洲药业关于召开2014年第四次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2014-10-31/603456_20141101_6.pdf
15,2014-11-01,九洲药业关于设立工程子公司的公告,/disclosure/listedinfo/announcement/c/2014-10-31/603456_20141101_7.pdf
16,2014-11-01,九洲药业关于公司购买理财产品的公告,/disclosure/listedinfo/announcement/c/2014-10-31/603456_20141101_4.pdf
17,2014-11-01,九洲药业股东大会议事规则,/disclosure/listedinfo/announcement/c/2014-10-31/603456_20141101_10.pdf
18,2014-11-01,九洲药业独立董事津贴制度,/disclosure/listedinfo/announcement/c/2014-10-31/603456_20141101_14.pdf
19,2014-11-01,九洲药业独立董事候选人声明及提名人声明,/disclosure/listedinfo/announcement/c/2014-10-31/603456_20141101_9.pdf
20,2014-11-01,九洲药业独立董事关于第四届董事会第十九次会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2014-10-31/603456_20141101_8.pdf
21,2014-11-01,九洲药业董事会秘书工作制度,/disclosure/listedinfo/announcement/c/2014-10-31/603456_20141101_13.pdf
22,2014-11-01,九洲药业第四届监事会第九次会议决议公告,/disclosure/listedinfo/announcement/c/2014-10-31/603456_20141101_2.pdf
23,2014-11-01,九洲药业第四届董事会第十九次会议决议公告,/disclosure/listedinfo/announcement/c/2014-10-31/603456_20141101_1.pdf
24,2014-11-12,九洲药业关于召开2014年第四次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2014-11-11/603456_20141112_1.pdf
25,2014-11-12,九洲药业关于选举职工监事的公告,/disclosure/listedinfo/announcement/c/2014-11-11/603456_20141112_2.pdf
26,2014-11-12,九洲药业2014年第四次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2014-11-11/603456_20141112_3.pdf
27,2014-11-18,九洲药业委托理财公告,/disclosure/listedinfo/announcement/c/2014-11-17/603456_20141118_3.pdf
28,2014-11-18,九洲药业2014年第四次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2014-11-17/603456_20141118_1.pdf
29,2014-11-18,九洲药业2014年第四次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2014-11-17/603456_20141118_2.pdf
30,2014-11-19,九洲药业独立董事关于第五届董事会第一次会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2014-11-18/603456_20141119_3.pdf
31,2014-11-19,九洲药业第五届监事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2014-11-18/603456_20141119_1.pdf
32,2014-11-19,九洲药业第五届董事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2014-11-18/603456_20141119_2.pdf
33,2014-12-04,九洲药业关于注册资本等事项完成工商变更登记的公告,/disclosure/listedinfo/announcement/c/2014-12-03/603456_20141204_1.pdf
34,2014-12-10,九洲药业关于媒体报道的澄清公告,/disclosure/listedinfo/announcement/c/2014-12-09/603456_20141210_1.pdf
35,2015-01-01,九洲药业关于委托理财的进展公告,/disclosure/listedinfo/announcement/c/2014-12-31/603456_20150101_1.pdf
36,2015-01-15,九洲药业：招商证券股份有限公司关于浙江九洲药业股份有限公司持续督导期间定期现场检查报告,/disclosure/listedinfo/announcement/c/2015-01-14/603456_20150115_1.pdf
37,2015-01-20,九洲药业关于临海分公司发生安全事故的公告,/disclosure/listedinfo/announcement/c/2015-01-19/603456_20150120_1.pdf
38,2015-02-10,九洲药业关于重大事项停牌公告,/disclosure/listedinfo/announcement/c/2015-02-09/603456_20150210_1.pdf
39,2015-02-14,九洲药业未来三年（2015-2017年）股东分红回报规划,/disclosure/listedinfo/announcement/c/2015-02-13/603456_20150214_5.pdf
40,2015-02-14,九洲药业前次募集资金使用情况鉴证报告,/disclosure/listedinfo/announcement/c/2015-02-13/603456_20150214_11.pdf
41,2015-02-14,九洲药业前次募集资金使用情况报告,/disclosure/listedinfo/announcement/c/2015-02-13/603456_20150214_7.pdf
42,2015-02-14,九洲药业关于召开2015年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2015-02-13/603456_20150214_3.pdf
43,2015-02-14,九洲药业关于公司股票复牌提示性公告,/disclosure/listedinfo/announcement/c/2015-02-13/603456_20150214_4.pdf
44,2015-02-14,九洲药业非公开发行股票募集资金使用可行性研究报告,/disclosure/listedinfo/announcement/c/2015-02-13/603456_20150214_10.pdf
45,2015-02-14,九洲药业独立董事关于第五届董事会第二次会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2015-02-13/603456_20150214_9.pdf
46,2015-02-14,九洲药业第五届监事会第二次会议决议公告,/disclosure/listedinfo/announcement/c/2015-02-13/603456_20150214_2.pdf
47,2015-02-14,九洲药业第五届董事会第二次会议决议公告,/disclosure/listedinfo/announcement/c/2015-02-13/603456_20150214_1.pdf
48,2015-02-14,九洲药业2015年度非公开发行A股股票预案,/disclosure/listedinfo/announcement/c/2015-02-13/603456_20150214_6.pdf
49,2015-03-06,九洲药业关于召开2015年第一次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2015-03-05/603456_20150306_1.pdf
50,2015-03-07,九洲药业2015年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2015-03-06/603456_20150307_1.pdf
51,2015-03-14,九洲药业关于公司通过高新技术企业重新认定的公告,/disclosure/listedinfo/announcement/c/2015-03-13/603456_20150314_1.pdf
52,2015-03-17,九洲药业2015年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2015-03-16/603456_20150317_1.pdf
53,2015-03-17,九洲药业2015年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2015-03-16/603456_20150317_2.pdf
54,2015-03-25,九洲药业关于设立工程子公司的进展公告,/disclosure/listedinfo/announcement/c/2015-03-24/603456_20150325_1.pdf
55,2015-04-03,九洲药业关于设立杭州子公司的公告,/disclosure/listedinfo/announcement/c/2015-04-02/603456_20150403_2.pdf
56,2015-04-03,九洲药业第五届董事会第三次会议决议公告,/disclosure/listedinfo/announcement/c/2015-04-02/603456_20150403_1.pdf
57,2015-04-08,九洲药业关于设立杭州子公司的进展公告,/disclosure/listedinfo/announcement/c/2015-04-07/603456_20150408_1.pdf
58,2015-04-11,九洲药业年报摘要,/disclosure/listedinfo/announcement/c/2015-04-10/603456_2014_nzy.pdf
59,2015-04-11,九洲药业年报信息披露重大差错责任追究制度,/disclosure/listedinfo/announcement/c/2015-04-10/603456_20150411_19.pdf
60,2015-04-11,九洲药业年报,/disclosure/listedinfo/announcement/c/2015-04-10/603456_2014_n.pdf
61,2015-04-11,九洲药业内部控制评价管理办法,/disclosure/listedinfo/announcement/c/2015-04-10/603456_20150411_18.pdf
62,2015-04-11,九洲药业关于召开2014年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2015-04-10/603456_20150411_7.pdf
63,2015-04-11,九洲药业关于确认2014年度关联交易暨2015年度日常关联交易预计的公告,/disclosure/listedinfo/announcement/c/2015-04-10/603456_20150411_5.pdf
64,2015-04-11,九洲药业关于公司2014年度募集资金存放与使用情况的专项报告,/disclosure/listedinfo/announcement/c/2015-04-10/603456_20150411_3.pdf
65,2015-04-11,九洲药业独立董事关于公司对外担保情况的专项说明及独立意见,/disclosure/listedinfo/announcement/c/2015-04-10/603456_20150411_9.pdf
66,2015-04-11,九洲药业独立董事关于公司2015年度日常关联交易预计的事前认可函,/disclosure/listedinfo/announcement/c/2015-04-10/603456_20150411_21.pdf
67,2015-04-11,九洲药业独立董事关于第五届董事会第四次会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2015-04-10/603456_20150411_20.pdf
68,2015-04-11,九洲药业独立董事2014年度述职报告,/disclosure/listedinfo/announcement/c/2015-04-10/603456_20150411_12.pdf
69,2015-04-11,九洲药业董事会审计委员会2014年度履职情况报告,/disclosure/listedinfo/announcement/c/2015-04-10/603456_20150411_16.pdf
70,2015-04-11,九洲药业董事、监事和高级管理人员薪酬管理制度,/disclosure/listedinfo/announcement/c/2015-04-10/603456_20150411_17.pdf
71,2015-04-11,九洲药业第五届监事会第三次会议决议公告,/disclosure/listedinfo/announcement/c/2015-04-10/603456_20150411_4.pdf
72,2015-04-11,九洲药业第五届董事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2015-04-10/603456_20150411_2.pdf
73,2015-04-11,九洲药业：招商证券股份有限公司关于浙江九洲药业股份有限公司关联交易的独立意见,/disclosure/listedinfo/announcement/c/2015-04-10/603456_20150411_22.pdf
74,2015-04-11,九洲药业：招商证券股份有限公司关于浙江九洲药业股份有限公司2014年度募集资金存放与使用情况专项核查意见,/disclosure/listedinfo/announcement/c/2015-04-10/603456_20150411_15.pdf
75,2015-04-11,九洲药业：招商证券股份有限公司关于浙江九洲药业股份有限公司2014年持续督导年度报告书,/disclosure/listedinfo/announcement/c/2015-04-10/603456_20150411_6.pdf
76,2015-04-11,九洲药业：募集资金年度存放与使用情况鉴证报告,/disclosure/listedinfo/announcement/c/2015-04-10/603456_20150411_14.pdf
77,2015-04-11,九洲药业：非经营性资金占用及其他关联资金往来情况的专项审计说明,/disclosure/listedinfo/announcement/c/2015-04-10/603456_20150411_11.pdf
78,2015-04-11,九洲药业2014年度审计报告,/disclosure/listedinfo/announcement/c/2015-04-10/603456_20150411_10.pdf
79,2015-04-11,九洲药业2014年度内部控制自我评价报告,/disclosure/listedinfo/announcement/c/2015-04-10/603456_20150411_13.pdf
80,2015-04-16,九洲药业关于土地及房产抵押贷款的公告,/disclosure/listedinfo/announcement/c/2015-04-15/603456_20150416_4.pdf
81,2015-04-16,九洲药业关于确认2014年度关联交易暨2015年度日常关联交易预计公告的补充公告,/disclosure/listedinfo/announcement/c/2015-04-15/603456_20150416_3.pdf
82,2015-04-16,九洲药业关于第五届监事会第三次会议决议的补充公告,/disclosure/listedinfo/announcement/c/2015-04-15/603456_20150416_2.pdf
83,2015-04-16,九洲药业关于第五届董事会第四次会议决议的补充公告,/disclosure/listedinfo/announcement/c/2015-04-15/603456_20150416_1.pdf
84,2015-04-21,九洲药业关于出售控股子公司股权的公告,/disclosure/listedinfo/announcement/c/2015-04-20/603456_20150421_2.pdf
85,2015-04-21,九洲药业独立董事关于第五届董事会第五次会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2015-04-20/603456_20150421_3.pdf
86,2015-04-21,九洲药业第五届董事会第五次会议决议公告,/disclosure/listedinfo/announcement/c/2015-04-20/603456_20150421_1.pdf
87,2015-04-22,九洲药业关于临海分公司安全事故的进展公告,/disclosure/listedinfo/announcement/c/2015-04-21/603456_20150422_3.pdf
88,2015-04-22,九洲药业：海宁三联化工有限公司审计报告,/disclosure/listedinfo/announcement/c/2015-04-21/603456_20150422_2.pdf
89,2015-04-22,九洲药业：海宁三联化工有限公司拟实施股权转让涉及的股东全部权益价值评估报告书,/disclosure/listedinfo/announcement/c/2015-04-21/603456_20150422_1.pdf
90,2015-04-24,九洲药业关于召开2014年年度股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2015-04-23/603456_20150424_3.pdf
91,2015-04-24,九洲药业关于筹划员工持股计划股票停牌的公告,/disclosure/listedinfo/announcement/c/2015-04-23/603456_20150424_2.pdf
92,2015-04-24,九洲药业关于变更保荐机构的公告,/disclosure/listedinfo/announcement/c/2015-04-23/603456_20150424_1.pdf
93,2015-04-29,九洲药业关于终止员工持股计划暨复牌的公告,/disclosure/listedinfo/announcement/c/2015-04-28/603456_20150429_1.pdf
94,2015-04-30,九洲药业关于召开2015年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2015-04-29/603456_20150430_5.pdf
95,2015-04-30,九洲药业关于控股股东为公司年度申请银行授信提供担保预计暨关联交易的公告,/disclosure/listedinfo/announcement/c/2015-04-29/603456_20150430_4.pdf
96,2015-04-30,九洲药业独立董事关于控股股东为公司年度申请银行授信提供担保预计暨关联交易的事前认可函,/disclosure/listedinfo/announcement/c/2015-04-29/603456_20150430_8.pdf
97,2015-04-30,九洲药业独立董事关于控股股东为公司年度申请银行授信提供担保预计暨关联交易的独立意见,/disclosure/listedinfo/announcement/c/2015-04-29/603456_20150430_7.pdf
98,2015-04-30,九洲药业第一季度季报,/disclosure/listedinfo/announcement/c/2015-04-29/603456_2015_1.pdf
99,2015-04-30,九洲药业第五届监事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2015-04-29/603456_20150430_3.pdf
100,2015-04-30,九洲药业第五届董事会第六次会议决议公告,/disclosure/listedinfo/announcement/c/2015-04-29/603456_20150430_2.pdf
101,2015-05-05,九洲药业关于非公开发行股票申请获中国证监会受理的公告,/disclosure/listedinfo/announcement/c/2015-05-04/603456_20150505_2.pdf
102,2015-05-05,九洲药业2014年年度大会会议资料,/disclosure/listedinfo/announcement/c/2015-05-04/603456_20150505_1.pdf
103,2015-05-09,九洲药业2014年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2015-05-08/603456_20150509_1.pdf
104,2015-05-09,九洲药业2014年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2015-05-08/603456_20150509_2.pdf
105,2015-05-12,九洲药业关于召开2015年第二次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2015-05-11/603456_20150512_1.pdf
106,2015-05-13,九洲药业2015年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2015-05-12/603456_20150513_1.pdf
107,2015-05-19,九洲药业2015年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2015-05-18/603456_20150519_1.pdf
108,2015-05-19,九洲药业2015年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2015-05-18/603456_20150519_2.pdf
109,2015-05-20,九洲药业2014年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2015-05-19/603456_20150520_1.pdf
110,2015-06-04,九洲药业关于签署股权转让意向性协议的提示性公告,/disclosure/listedinfo/announcement/c/2015-06-03/603456_20150604_1.pdf
111,2015-06-13,九洲药业关于调整非公开发行股票发行底价和发行数量的公告,/disclosure/listedinfo/announcement/c/2015-06-12/603456_20150613_1.pdf
112,2015-06-27,九洲药业拟收购股权涉及的江苏瑞克医药科技有限公司股东全部权益价值评估项目资产评估报告,/disclosure/listedinfo/announcement/c/2015-06-26/603456_20150627_6.pdf
113,2015-06-27,九洲药业关于收购江苏瑞克医药科技有限公司80%股权并增资的公告,/disclosure/listedinfo/announcement/c/2015-06-26/603456_20150627_3.pdf
114,2015-06-27,九洲药业关于设立子公司的公告,/disclosure/listedinfo/announcement/c/2015-06-26/603456_20150627_2.pdf
115,2015-06-27,九洲药业独立董事关于第五届董事会第七次会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2015-06-26/603456_20150627_4.pdf
116,2015-06-27,九洲药业第五届董事会第七次会议决议公告,/disclosure/listedinfo/announcement/c/2015-06-26/603456_20150627_1.pdf
117,2015-06-27,九洲药业：江苏瑞克医药科技有限公司2014年-2015年4月审计报告,/disclosure/listedinfo/announcement/c/2015-06-26/603456_20150627_5.pdf
118,2015-07-02,九洲药业关于筹划员工持股计划股票停牌的公告,/disclosure/listedinfo/announcement/c/2015-07-01/603456_20150702_1.pdf
119,2015-07-09,九洲药业关于筹划员工持股计划股票停牌的进展公告,/disclosure/listedinfo/announcement/c/2015-07-08/603456_20150709_1.pdf
120,2015-07-11,九洲药业监事会关于员工持股计划相关事项的审核意见,/disclosure/listedinfo/announcement/c/2015-07-10/603456_20150711_9.pdf
121,2015-07-11,九洲药业关于召开2015年第三次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2015-07-10/603456_20150711_5.pdf
122,2015-07-11,九洲药业关于为全资子公司提供借款和提供担保额度的公告,/disclosure/listedinfo/announcement/c/2015-07-10/603456_20150711_4.pdf
123,2015-07-11,九洲药业关于公司股票复牌的提示性公告,/disclosure/listedinfo/announcement/c/2015-07-10/603456_20150711_6.pdf
124,2015-07-11,九洲药业关于调整非公开发行股票方案决议有效期和授权有效期的公告,/disclosure/listedinfo/announcement/c/2015-07-10/603456_20150711_3.pdf
125,2015-07-11,九洲药业独立董事关于第五届董事会第八次会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2015-07-10/603456_20150711_8.pdf
126,2015-07-11,九洲药业第五届监事会第五次会议决议公告,/disclosure/listedinfo/announcement/c/2015-07-10/603456_20150711_2.pdf
127,2015-07-11,九洲药业第五届董事会第八次会议决议公告,/disclosure/listedinfo/announcement/c/2015-07-10/603456_20150711_1.pdf
128,2015-07-11,九洲药业：中信证券九洲药业员工共赢1号定向资产管理计划资产管理合同,/disclosure/listedinfo/announcement/c/2015-07-10/603456_20150711_11.pdf
129,2015-07-11,九洲药业2015年度员工持股计划摘要（草案）,/disclosure/listedinfo/announcement/c/2015-07-10/603456_20150711_7.pdf
130,2015-07-11,九洲药业2015年度员工持股计划（草案）,/disclosure/listedinfo/announcement/c/2015-07-10/603456_20150711_10.pdf
131,2015-07-15,九洲药业关于召开2015年第三次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2015-07-14/603456_20150715_1.pdf
132,2015-07-15,九洲药业2015年第三次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2015-07-14/603456_20150715_2.pdf
133,2015-07-23,九洲药业：浙江天册律师事务所关于浙江九洲药业股份有限公司实施员工持股计划的法律意见书,/disclosure/listedinfo/announcement/c/2015-07-22/603456_20150723_1.pdf
134,2015-07-28,九洲药业2015年第三次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2015-07-27/603456_20150728_1.pdf
135,2015-07-28,九洲药业2015年第三次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2015-07-27/603456_20150728_2.pdf
136,2015-07-31,九洲药业半年报摘要,/disclosure/listedinfo/announcement/c/2015-07-30/603456_2015_zzy.pdf
137,2015-07-31,九洲药业半年报,/disclosure/listedinfo/announcement/c/2015-07-30/603456_2015_z.pdf
138,2015-08-05,九洲药业关于申请延期提交非公开发行股票申请材料反馈意见书面回复的公告,/disclosure/listedinfo/announcement/c/2015-08-05/603456_20150805_1.pdf
139,2015-08-08,九洲药业关于设立子公司的进展公告,/disclosure/listedinfo/announcement/c/2015-08-08/603456_20150808_1.pdf
140,2015-08-08,九洲药业关于非公开发行股票摊薄即期回报对公司主要财务指标的影响及填补措施的公告,/disclosure/listedinfo/announcement/c/2015-08-08/603456_20150808_3.pdf
141,2015-08-08,九洲药业关于非公开发行股票申请文件反馈意见回复的公告,/disclosure/listedinfo/announcement/c/2015-08-08/603456_20150808_2.pdf
142,2015-08-08,九洲药业非公开发行股票申请文件反馈意见之回复报告,/disclosure/listedinfo/announcement/c/2015-08-08/603456_20150808_4.pdf
143,2015-09-01,九洲药业关于员工持股计划实施进展的公告,/disclosure/listedinfo/announcement/c/2015-09-01/603456_20150901_1.pdf
144,2015-09-12,九洲药业关于首次公开发行全部募投项目结项并注销募集资金专户的公告,/disclosure/listedinfo/announcement/c/2015-09-12/603456_20150912_1.pdf
145,2015-09-26,九洲药业关于员工持股计划完成股票购买的公告,/disclosure/listedinfo/announcement/c/2015-09-26/603456_20150926_1.pdf
146,2015-09-30,九洲药业首次公开发行限售股上市流通公告,/disclosure/listedinfo/announcement/c/2015-09-30/603456_20150930_1.pdf
147,2015-09-30,九洲药业：中信证券股份有限公司关于浙江九洲药业股份有限公司首次公开发行限售股上市流通的核查意见,/disclosure/listedinfo/announcement/c/2015-09-30/603456_20150930_2.pdf
148,2015-10-15,九洲药业关于非公开发行股票申请获得中国证监会发行审核委员会审核通过的公告,/disclosure/listedinfo/announcement/c/2015-10-15/603456_20151015_1.pdf
149,2015-10-28,九洲药业第三季度季报,/disclosure/listedinfo/announcement/c/2015-10-28/603456_2015_3.pdf
150,2015-10-31,九洲药业关于印度对原产于中国的格列齐特反倾销作出终裁的公告,/disclosure/listedinfo/announcement/c/2015-10-31/603456_20151031_1.pdf
151,2015-11-10,九洲药业关于非公开发行股票申请获得中国证监会核准批文的公告,/disclosure/listedinfo/announcement/c/2015-11-10/603456_20151110_1.pdf
152,2015-12-05,九洲药业验资报告,/disclosure/listedinfo/announcement/c/2015-12-05/603456_20151205_9.pdf
153,2015-12-05,九洲药业内部控制缺陷认定标准,/disclosure/listedinfo/announcement/c/2015-12-05/603456_20151205_13.pdf
154,2015-12-05,九洲药业关于以非公开发行股票募集资金置换预先投入自筹资金的公告,/disclosure/listedinfo/announcement/c/2015-12-05/603456_20151205_5.pdf
155,2015-12-05,九洲药业关于修改《公司章程》的公告,/disclosure/listedinfo/announcement/c/2015-12-05/603456_20151205_4.pdf
156,2015-12-05,九洲药业关于使用部分暂时闲置募集资金购买理财产品的公告,/disclosure/listedinfo/announcement/c/2015-12-05/603456_20151205_6.pdf
157,2015-12-05,九洲药业关于签署募集资金专户存储三方监管协议的公告,/disclosure/listedinfo/announcement/c/2015-12-05/603456_20151205_8.pdf
158,2015-12-05,九洲药业关于非公开发行股票发行结果暨股本变动公告,/disclosure/listedinfo/announcement/c/2015-12-05/603456_20151205_1.pdf
159,2015-12-05,九洲药业关于对全资子公司提供借款或担保额度的公告,/disclosure/listedinfo/announcement/c/2015-12-05/603456_20151205_7.pdf
160,2015-12-05,九洲药业公司章程（2015修订）,/disclosure/listedinfo/announcement/c/2015-12-05/603456_20151205_14.pdf
161,2015-12-05,九洲药业非公开发行股票的发行情况报告书,/disclosure/listedinfo/announcement/c/2015-12-05/603456_20151205_12.pdf
162,2015-12-05,九洲药业第五届监事会第八次会议决议公告,/disclosure/listedinfo/announcement/c/2015-12-05/603456_20151205_3.pdf
163,2015-12-05,九洲药业第五届董事会第十一次会议决议公告,/disclosure/listedinfo/announcement/c/2015-12-05/603456_20151205_2.pdf
164,2015-12-05,九洲药业：中信证券股份有限公司关于浙江九洲药业股份有限公司使用募集资金置换预先已投入募投项目的自筹资金的核查意见,/disclosure/listedinfo/announcement/c/2015-12-05/603456_20151205_15.pdf
165,2015-12-05,九洲药业：中信证券股份有限公司关于浙江九州药业股份有限公司使用部分闲置募集资金购买理财产品的核查意见,/disclosure/listedinfo/announcement/c/2015-12-05/603456_20151205_17.pdf
166,2015-12-05,九洲药业：浙江天册律师事务所关于浙江九洲药业股份有限公司2015年度非公开发行股票发行过程及认购对象合规性的法律意见书,/disclosure/listedinfo/announcement/c/2015-12-05/603456_20151205_10.pdf
167,2015-12-05,九洲药业：关于浙江九洲药业股份有限公司以自筹资金预先投入募投项目的鉴证报告,/disclosure/listedinfo/announcement/c/2015-12-05/603456_20151205_16.pdf
168,2015-12-05,九洲药业：保荐机构及联席主承销商关于浙江九洲药业股份有限公司非公开发行股票发行过程和认购对象合规性的报告,/disclosure/listedinfo/announcement/c/2015-12-05/603456_20151205_11.pdf
169,2015-12-10,九洲药业关于董事辞职的公告,/disclosure/listedinfo/announcement/c/2015-12-10/603456_20151210_1.pdf
170,2015-12-15,九洲药业关于召开2015年第四次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2015-12-15/603456_20151215_4.pdf
171,2015-12-15,九洲药业关于对全资子公司增资、变更经营范围并更名的公告,/disclosure/listedinfo/announcement/c/2015-12-15/603456_20151215_1.pdf
172,2015-12-15,九洲药业关于对全资子公司提供借款额度的公告,/disclosure/listedinfo/announcement/c/2015-12-15/603456_20151215_2.pdf
173,2015-12-15,九洲药业独立董事关于第五届董事会第十二次会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2015-12-15/603456_20151215_5.pdf
174,2015-12-15,九洲药业第五届董事会第十二次会议决议公告,/disclosure/listedinfo/announcement/c/2015-12-15/603456_20151215_3.pdf
175,2015-12-16,九洲药业关于全资子公司竞拍取得土地使用权的公告,/disclosure/listedinfo/announcement/c/2015-12-16/603456_20151216_1.pdf
176,2015-12-19,九洲药业关于更换保荐代表人的公告,/disclosure/listedinfo/announcement/c/2015-12-19/603456_20151219_1.pdf
177,2015-12-22,九洲药业2015年第四次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2015-12-22/603456_20151222_1.pdf
178,2015-12-24,九洲药业关于控股股东部分股权质押的公告,/disclosure/listedinfo/announcement/c/2015-12-24/603456_20151224_1.pdf
179,2015-12-25,九洲药业关于召开2015年第四次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2015-12-25/603456_20151225_1.pdf
180,2015-12-31,九洲药业2015年第四次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2015-12-31/603456_20151231_1.pdf
181,2015-12-31,九洲药业2015年第四次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2015-12-31/603456_20151231_2.pdf
182,2016-01-01,九洲药业关于完成非公开发行股票工商变更登记的公告,/disclosure/listedinfo/announcement/c/2016-01-01/603456_20160101_1.pdf
183,2016-01-25,九洲药业关于签署成立合资公司意向书及股权转让意向性协议的提示性公告,/disclosure/listedinfo/announcement/c/2016-01-25/603456_20160125_1.pdf
184,2016-01-28,九洲药业2015年度业绩预增公告,/disclosure/listedinfo/announcement/c/2016-01-28/603456_20160128_1.pdf
185,2016-02-23,九洲药业关于与诺华爱尔兰公司签订商业供货协议的提示性公告,/disclosure/listedinfo/announcement/c/2016-02-23/603456_20160223_1.pdf
186,2016-02-24,九洲药业关于与诺华爱尔兰公司签订商业供货协议的补充公告,/disclosure/listedinfo/announcement/c/2016-02-24/603456_20160224_1.pdf
187,2016-02-27,九洲药业关于获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-02-27/603456_20160227_1.pdf
188,2016-03-17,九洲药业关于2015年度利润分配及资本公积金转增股本预案的预披露公告,/disclosure/listedinfo/announcement/c/2016-03-17/603456_20160317_1.pdf
189,2016-03-23,九洲药业关于控股股东部分股权质押的公告,/disclosure/listedinfo/announcement/c/2016-03-23/603456_20160323_1.pdf
190,2016-03-24,九洲药业关于变更公司投资者联系方式的公告,/disclosure/listedinfo/announcement/c/2016-03-24/603456_20160324_1.pdf
191,2016-04-08,九洲药业年报摘要,/disclosure/listedinfo/announcement/c/2016-04-08/603456_2015_nzy.pdf
192,2016-04-08,九洲药业年报,/disclosure/listedinfo/announcement/c/2016-04-08/603456_2015_n.pdf
193,2016-04-08,九洲药业内部控制审计报告,/disclosure/listedinfo/announcement/c/2016-04-08/603456_20160408_25.pdf
194,2016-04-08,九洲药业募集资金年度存放与使用情况鉴证报告,/disclosure/listedinfo/announcement/c/2016-04-08/603456_20160408_24.pdf
195,2016-04-08,九洲药业关于注销全资子公司的公告,/disclosure/listedinfo/announcement/c/2016-04-08/603456_20160408_9.pdf
196,2016-04-08,九洲药业关于召开2015年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2016-04-08/603456_20160408_10.pdf
197,2016-04-08,九洲药业关于以暂时闲置募集资金临时补充流动资金的公告,/disclosure/listedinfo/announcement/c/2016-04-08/603456_20160408_13.pdf
198,2016-04-08,九洲药业关于土地及房产抵押贷款的公告,/disclosure/listedinfo/announcement/c/2016-04-08/603456_20160408_17.pdf
199,2016-04-08,九洲药业关于使用暂时闲置募集资金购买理财产品的公告,/disclosure/listedinfo/announcement/c/2016-04-08/603456_20160408_11.pdf
200,2016-04-08,九洲药业关于使用闲置自有资金开展理财业务的公告,/disclosure/listedinfo/announcement/c/2016-04-08/603456_20160408_12.pdf
201,2016-04-08,九洲药业关于确认公司2015年度关联交易的公告,/disclosure/listedinfo/announcement/c/2016-04-08/603456_20160408_4.pdf
202,2016-04-08,九洲药业关于控股股东为公司年度申请银行授信提供担保预计暨关联交易的公告,/disclosure/listedinfo/announcement/c/2016-04-08/603456_20160408_6.pdf
203,2016-04-08,九洲药业关于公司董事会审议高送转的公告,/disclosure/listedinfo/announcement/c/2016-04-08/603456_20160408_8.pdf
204,2016-04-08,九洲药业关于公司董事、财务负责人辞职的公告,/disclosure/listedinfo/announcement/c/2016-04-08/603456_20160408_14.pdf
205,2016-04-08,九洲药业关于公司2016年度对全资子公司提供借款和提供担保额度的公告,/disclosure/listedinfo/announcement/c/2016-04-08/603456_20160408_7.pdf
206,2016-04-08,九洲药业关于公司2015年度募集资金存放与使用情况的专项报告,/disclosure/listedinfo/announcement/c/2016-04-08/603456_20160408_5.pdf
207,2016-04-08,九洲药业独立董事关于控股股东为公司年度申请银行授信提供担保预计暨关联交易的事前认可函,/disclosure/listedinfo/announcement/c/2016-04-08/603456_20160408_29.pdf
208,2016-04-08,九洲药业独立董事关于公司对外担保情况的专项说明及独立意见,/disclosure/listedinfo/announcement/c/2016-04-08/603456_20160408_19.pdf
209,2016-04-08,九洲药业独立董事关于第五届董事会第十三次会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2016-04-08/603456_20160408_27.pdf
210,2016-04-08,九洲药业独立董事2015年度述职报告,/disclosure/listedinfo/announcement/c/2016-04-08/603456_20160408_22.pdf
211,2016-04-08,九洲药业董事会审计委员会2015年度履职报告,/disclosure/listedinfo/announcement/c/2016-04-08/603456_20160408_26.pdf
212,2016-04-08,九洲药业第五届监事会第九次会议决议公告,/disclosure/listedinfo/announcement/c/2016-04-08/603456_20160408_3.pdf
213,2016-04-08,九洲药业第五届董事会第十三次会议决议公告,/disclosure/listedinfo/announcement/c/2016-04-08/603456_20160408_2.pdf
214,2016-04-08,九洲药业：中信证券股份有限公司关于浙江九洲药业股份有限公司使用暂时闲置募集资金临时补充流动资金的核查意见,/disclosure/listedinfo/announcement/c/2016-04-08/603456_20160408_31.pdf
215,2016-04-08,九洲药业：中信证券股份有限公司关于浙江九洲药业股份有限公司使用部分闲置募集资金购买理财产品的核查意见,/disclosure/listedinfo/announcement/c/2016-04-08/603456_20160408_30.pdf
216,2016-04-08,九洲药业：中信证券股份有限公司关于浙江九洲药业股份有限公司2015年度募集资金存放与使用情况的专项核查报告,/disclosure/listedinfo/announcement/c/2016-04-08/603456_20160408_28.pdf
217,2016-04-08,九洲药业：中信证券股份有限公司关于浙江九洲药业股份有限公司2015年度持续督导现场检查报告,/disclosure/listedinfo/announcement/c/2016-04-08/603456_20160408_16.pdf
218,2016-04-08,九洲药业：中信证券股份有限公司关于浙江九洲药业股份有限公司2015年度持续督导报告书,/disclosure/listedinfo/announcement/c/2016-04-08/603456_20160408_15.pdf
219,2016-04-08,九洲药业：非经营性资金占用及其他关联资金往来情况的专项审计说明,/disclosure/listedinfo/announcement/c/2016-04-08/603456_20160408_21.pdf
220,2016-04-08,九洲药业2015年度审计报告,/disclosure/listedinfo/announcement/c/2016-04-08/603456_20160408_20.pdf
221,2016-04-08,九洲药业2015年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2016-04-08/603456_20160408_23.pdf
222,2016-04-09,九洲药业关于开展远期结售汇业务的公告,/disclosure/listedinfo/announcement/c/2016-04-09/603456_20160409_1.pdf
223,2016-04-20,九洲药业2015年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2016-04-20/603456_20160420_1.pdf
224,2016-04-23,九洲药业关于召开2015年年度股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2016-04-23/603456_20160423_1.pdf
225,2016-04-26,九洲药业关于设立子公司的公告,/disclosure/listedinfo/announcement/c/2016-04-26/603456_20160426_3.pdf
226,2016-04-26,九洲药业第五届董事会第十四次会议决议公告,/disclosure/listedinfo/announcement/c/2016-04-26/603456_20160426_2.pdf
227,2016-04-26,九洲药业2016年第一季度报告,/disclosure/listedinfo/announcement/c/2016-04-26/603456_2016_1.pdf
228,2016-04-29,九洲药业2015年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2016-04-29/603456_20160429_1.pdf
229,2016-04-29,九洲药业2015年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2016-04-29/603456_20160429_2.pdf
230,2016-05-07,九洲药业关于设立子公司的进展公告,/disclosure/listedinfo/announcement/c/2016-05-07/603456_20160507_1.pdf
231,2016-05-19,九洲药业2015年度利润分配及资本公积金转增股本实施公告,/disclosure/listedinfo/announcement/c/2016-05-19/603456_20160519_1.pdf
232,2016-06-07,九洲药业关于对外投资设立合资公司的公告,/disclosure/listedinfo/announcement/c/2016-06-07/603456_20160607_2.pdf
233,2016-06-07,九洲药业独立董事关于第五届董事会第十五次会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2016-06-07/603456_20160607_3.pdf
234,2016-06-07,九洲药业第五届董事会第十五次会议决议公告,/disclosure/listedinfo/announcement/c/2016-06-07/603456_20160607_1.pdf
235,2016-06-17,九洲药业关于控股股东股权解除质押及再质押的公告,/disclosure/listedinfo/announcement/c/2016-06-17/603456_20160617_1.pdf
236,2016-06-25,九洲药业2016年半年度业绩预减公告,/disclosure/listedinfo/announcement/c/2016-06-25/603456_20160625_1.pdf
237,2016-07-01,九洲药业关于召开2016年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2016-07-01/603456_20160701_6.pdf
238,2016-07-01,九洲药业关于收购方达医药技术（苏州）有限公司25%股权的公告,/disclosure/listedinfo/announcement/c/2016-07-01/603456_20160701_3.pdf
239,2016-07-01,九洲药业关于全资子公司以暂时闲置募集资金临时补充流动资金的公告,/disclosure/listedinfo/announcement/c/2016-07-01/603456_20160701_2.pdf
240,2016-07-01,九洲药业关于变更部分募集资金投资项目实施主体由分公司变为全资子公司暨对全资子公司增资的公告,/disclosure/listedinfo/announcement/c/2016-07-01/603456_20160701_1.pdf
241,2016-07-01,九洲药业独立董事关于第五届董事会第十六次会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2016-07-01/603456_20160701_9.pdf
242,2016-07-01,九洲药业第五届监事会第十一次会议决议公告,/disclosure/listedinfo/announcement/c/2016-07-01/603456_20160701_5.pdf
243,2016-07-01,九洲药业第五届董事会第十六次会议决议公告,/disclosure/listedinfo/announcement/c/2016-07-01/603456_20160701_4.pdf
244,2016-07-01,九洲药业：中信证券股份有限公司关于浙江九洲药业股份有限公司使用暂时闲置募集资金临时补充子公司流动资金的核查意见,/disclosure/listedinfo/announcement/c/2016-07-01/603456_20160701_8.pdf
245,2016-07-01,九洲药业：中信证券股份有限公司关于浙江九洲药业股份有限公司变更部分非公开发行募投项目实施主体的核查意见,/disclosure/listedinfo/announcement/c/2016-07-01/603456_20160701_7.pdf
246,2016-07-02,九洲药业关于收购方达医药技术（苏州）有限公司25%股权的补充公告,/disclosure/listedinfo/announcement/c/2016-07-02/603456_20160702_1.pdf
247,2016-07-08,九洲药业2016年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2016-07-08/603456_20160708_1.pdf
248,2016-07-13,九洲药业关于召开2016年第一次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2016-07-13/603456_20160713_2.pdf
249,2016-07-13,九洲药业关于设立合资公司的进展公告,/disclosure/listedinfo/announcement/c/2016-07-13/603456_20160713_1.pdf
250,2016-07-14,九洲药业关于完成工商变更登记的公告,/disclosure/listedinfo/announcement/c/2016-07-14/603456_20160714_1.pdf
251,2016-07-14,九洲药业关于FDA对公司外沙厂区进口警示解除的公告,/disclosure/listedinfo/announcement/c/2016-07-14/603456_20160714_2.pdf
252,2016-07-16,九洲药业关于提前归还部分用于临时补充流动资金的募集资金的公告,/disclosure/listedinfo/announcement/c/2016-07-16/603456_20160716_1.pdf
253,2016-07-19,九洲药业2016年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2016-07-19/603456_20160719_1.pdf
254,2016-07-19,九洲药业2016年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2016-07-19/603456_20160719_2.pdf
255,2016-07-23,九洲药业关于部分募投项目实施主体变更后签订募集资金四方监管协议的公告,/disclosure/listedinfo/announcement/c/2016-07-23/603456_20160723_1.pdf
256,2016-07-27,九洲药业关于部分募投项目实施主体变更后注销原有募集资金专户的公告,/disclosure/listedinfo/announcement/c/2016-07-27/603456_20160727_1.pdf
257,2016-08-26,九洲药业关于参与设立石河子隆基投资管理合伙企业（有限合伙）的公告,/disclosure/listedinfo/announcement/c/2016-08-26/603456_20160826_1.pdf
258,2016-08-27,九洲药业关于公司2016年半年度募集资金存放与使用情况的专项报告,/disclosure/listedinfo/announcement/c/2016-08-27/603456_20160827_3.pdf
259,2016-08-27,九洲药业第五届监事会第十二次会议决议公告,/disclosure/listedinfo/announcement/c/2016-08-27/603456_20160827_4.pdf
260,2016-08-27,九洲药业第五届董事会第十七次会议决议公告,/disclosure/listedinfo/announcement/c/2016-08-27/603456_20160827_2.pdf
261,2016-08-27,九洲药业2016年半年度报告摘要,/disclosure/listedinfo/announcement/c/2016-08-27/603456_2016_zzy.pdf
262,2016-08-27,九洲药业2016年半年度报告,/disclosure/listedinfo/announcement/c/2016-08-27/603456_2016_z.pdf
263,2016-09-21,九洲药业关于更换保荐代表人的公告,/disclosure/listedinfo/announcement/c/2016-09-21/603456_20160921_1.pdf
264,2016-09-27,九洲药业关于证券事务代表辞职的公告,/disclosure/listedinfo/announcement/c/2016-09-27/603456_20160927_1.pdf
265,2016-10-01,九洲药业关于FDA对公司全资子公司浙江中贝九洲进出口有限公司进口警示解除的公告,/disclosure/listedinfo/announcement/c/2016-10-01/603456_20161001_1.pdf
266,2016-10-27,九洲药业2016年第三季度报告,/disclosure/listedinfo/announcement/c/2016-10-27/603456_2016_3.pdf
267,2016-10-28,九洲药业关于控股股东部分股权质押的公告,/disclosure/listedinfo/announcement/c/2016-10-28/603456_20161028_1.pdf
268,2016-11-05,九洲药业关于临海分公司通过FDA认证的公告,/disclosure/listedinfo/announcement/c/2016-11-05/603456_20161105_1.pdf
269,2016-11-08,九洲药业关于完成全资子公司注销登记的公告,/disclosure/listedinfo/announcement/c/2016-11-08/603456_20161108_1.pdf
270,2016-11-08,九洲药业关于临海分公司通过FDA认证的补充公告,/disclosure/listedinfo/announcement/c/2016-11-08/603456_20161108_2.pdf
271,2016-11-30,九洲药业非公开发行限售股上市流通公告,/disclosure/listedinfo/announcement/c/2016-11-30/603456_20161130_1.pdf
272,2016-11-30,九洲药业：中信证券股份有限公司关于浙江九洲药业股份有限公司非公开发行限售股份上市流通的核查意见,/disclosure/listedinfo/announcement/c/2016-11-30/603456_20161130_2.pdf
273,2016-12-29,九洲药业总经理工作细则,/disclosure/listedinfo/announcement/c/2016-12-29/603456_20161229_3.pdf
274,2016-12-29,九洲药业内幕信息知情人登记管理制度,/disclosure/listedinfo/announcement/c/2016-12-29/603456_20161229_5.pdf
275,2016-12-29,九洲药业内部控制缺陷认定标准,/disclosure/listedinfo/announcement/c/2016-12-29/603456_20161229_4.pdf
276,2016-12-29,九洲药业关于董事长、总经理等高级管理人员变更的公告,/disclosure/listedinfo/announcement/c/2016-12-29/603456_20161229_2.pdf
277,2016-12-29,九洲药业独立董事关于选举董事长及聘任高级管理人员的独立意见,/disclosure/listedinfo/announcement/c/2016-12-29/603456_20161229_6.pdf
278,2016-12-29,九洲药业第五届董事会第十九次会议决议公告,/disclosure/listedinfo/announcement/c/2016-12-29/603456_20161229_1.pdf
279,2016-12-30,九洲药业关于指定信息披露媒体变更的公告,/disclosure/listedinfo/announcement/c/2016-12-30/603456_20161230_1.pdf
280,2017-01-05,九洲药业关于全资子公司竞拍取得土地使用权的公告,/disclosure/listedinfo/announcement/c/2017-01-05/603456_20170105_1.pdf
281,2017-01-05,九洲药业关于公司全资子公司获得国家高新技术企业认定的公告,/disclosure/listedinfo/announcement/c/2017-01-05/603456_20170105_2.pdf
282,2017-01-24,九洲药业关于全资子公司增加注册资本并完成工商变更登记的公告,/disclosure/listedinfo/announcement/c/2017-01-24/603456_20170124_3.pdf
283,2017-01-24,九洲药业关于公司员工持股计划的提示性公告,/disclosure/listedinfo/announcement/c/2017-01-24/603456_20170124_2.pdf
284,2017-01-24,九洲药业关于公司高级管理人员辞职的公告,/disclosure/listedinfo/announcement/c/2017-01-24/603456_20170124_1.pdf
285,2017-02-09,九洲药业关于提前归还部分募集资金的公告,/disclosure/listedinfo/announcement/c/2017-02-09/603456_20170209_2.pdf
286,2017-02-09,九洲药业关于公司全资子公司获得高新技术企业认定的公告,/disclosure/listedinfo/announcement/c/2017-02-09/603456_20170209_1.pdf
287,2017-03-24,九洲药业关于控股股东股权解除质押及再质押的公告,/disclosure/listedinfo/announcement/c/2017-03-24/603456_20170324_1.pdf
288,2017-04-06,九洲药业关于归还募集资金的公告,/disclosure/listedinfo/announcement/c/2017-04-06/603456_20170406_1.pdf
289,2017-04-19,九洲药业关于归还募集资金的公告,/disclosure/listedinfo/announcement/c/2017-04-19/603456_20170419_1.pdf
290,2017-04-21,九洲药业关于召开2016年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2017-04-21/603456_20170421_13.pdf
291,2017-04-21,九洲药业关于以自有资产抵押向银行申请授信额度的公告,/disclosure/listedinfo/announcement/c/2017-04-21/603456_20170421_9.pdf
292,2017-04-21,九洲药业关于使用暂时闲置募集资金临时补充流动资金公告,/disclosure/listedinfo/announcement/c/2017-04-21/603456_20170421_11.pdf
293,2017-04-21,九洲药业关于使用闲置自有资金开展理财业务的公告,/disclosure/listedinfo/announcement/c/2017-04-21/603456_20170421_12.pdf
294,2017-04-21,九洲药业关于控股股东为公司及子公司2017年度申请银行授信提供担保暨关联交易的公告,/disclosure/listedinfo/announcement/c/2017-04-21/603456_20170421_4.pdf
295,2017-04-21,九洲药业关于公司2017年度向全资子公司提供借款和提供担保额度的公告,/disclosure/listedinfo/announcement/c/2017-04-21/603456_20170421_5.pdf
296,2017-04-21,九洲药业关于公司2017年度向全资子公司提供担保额度的公告,/disclosure/listedinfo/announcement/c/2017-04-21/603456_20170421_6.pdf
297,2017-04-21,九洲药业关于公司2017年度开展远期结售汇业务的公告,/disclosure/listedinfo/announcement/c/2017-04-21/603456_20170421_7.pdf
298,2017-04-21,九洲药业关于公司2017年度对全资子公司增资的公告,/disclosure/listedinfo/announcement/c/2017-04-21/603456_20170421_10.pdf
299,2017-04-21,九洲药业关于公司2016年度募集资金存放与使用情况的专项报告,/disclosure/listedinfo/announcement/c/2017-04-21/603456_20170421_18.pdf
300,2017-04-21,九洲药业关于公司2016年度募集资金存放与使用情况的专项报告,/disclosure/listedinfo/announcement/c/2017-04-21/603456_20170421_8.pdf
301,2017-04-21,九洲药业关于调整独立董事津贴的公告,/disclosure/listedinfo/announcement/c/2017-04-21/603456_20170421_14.pdf
302,2017-04-21,九洲药业独立董事津贴制度,/disclosure/listedinfo/announcement/c/2017-04-21/603456_20170421_23.pdf
303,2017-04-21,九洲药业独立董事关于第五届董事会第二十次会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2017-04-21/603456_20170421_27.pdf
304,2017-04-21,九洲药业独立董事2016年度述职报告,/disclosure/listedinfo/announcement/c/2017-04-21/603456_20170421_17.pdf
305,2017-04-21,九洲药业第五届监事会第十四次会议决议公告,/disclosure/listedinfo/announcement/c/2017-04-21/603456_20170421_3.pdf
306,2017-04-21,九洲药业第五届董事会审计委员会2016年度履职报告,/disclosure/listedinfo/announcement/c/2017-04-21/603456_20170421_22.pdf
307,2017-04-21,九洲药业第五届董事会第二十次会议决议公告,/disclosure/listedinfo/announcement/c/2017-04-21/603456_20170421_2.pdf
308,2017-04-21,九洲药业：中信证券股份有限公司关于浙江九洲药业股份有限公司使用暂时闲置募集资金临时补充流动资金的核查意见,/disclosure/listedinfo/announcement/c/2017-04-21/603456_20170421_24.pdf
309,2017-04-21,九洲药业：中信证券股份有限公司关于浙江九洲药业股份有限公司2016年度募集资金存放与使用情况的专项核查报告,/disclosure/listedinfo/announcement/c/2017-04-21/603456_20170421_21.pdf
310,2017-04-21,九洲药业：中信证券股份有限公司关于浙江九洲药业股份有限公司2016年度持续督导现场检查报告,/disclosure/listedinfo/announcement/c/2017-04-21/603456_20170421_16.pdf
311,2017-04-21,九洲药业：中信证券股份有限公司关于浙江九洲药业股份有限公司2016年度持续督导报告书,/disclosure/listedinfo/announcement/c/2017-04-21/603456_20170421_15.pdf
312,2017-04-21,九洲药业：天健会计师事务所关于公司募集资金年度存放与使用情况的鉴证报告,/disclosure/listedinfo/announcement/c/2017-04-21/603456_20170421_19.pdf
313,2017-04-21,九洲药业：天健会计师事务所关于公司2016年度非经营性资金占用及其他关联资金往来情况的专项审计说明,/disclosure/listedinfo/announcement/c/2017-04-21/603456_20170421_25.pdf
314,2017-04-21,九洲药业：内部控制审计报告,/disclosure/listedinfo/announcement/c/2017-04-21/603456_20170421_20.pdf
315,2017-04-21,九洲药业：2016年度审计报告,/disclosure/listedinfo/announcement/c/2017-04-21/603456_20170421_28.pdf
316,2017-04-21,九洲药业2016年年度报告摘要,/disclosure/listedinfo/announcement/c/2017-04-21/603456_2016_nzy.pdf
317,2017-04-21,九洲药业2016年年度报告,/disclosure/listedinfo/announcement/c/2017-04-21/603456_2016_n.pdf
318,2017-04-24,九洲药业关于续聘天健会计师事务所（特殊普通合伙）为公司2017年度财务、内控审计机构的公告,/disclosure/listedinfo/announcement/c/2017-04-24/603456_20170424_1.pdf
319,2017-04-24,九洲药业2016年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2017-04-24/603456_20170424_2.pdf
320,2017-04-27,九洲药业2017年第一季度报告,/disclosure/listedinfo/announcement/c/2017-04-27/603456_2017_1.pdf
321,2017-05-03,九洲药业2016年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2017-05-03/603456_20170503_1.pdf
322,2017-05-05,九洲药业关于与山东绿叶制药有限公司签订原料药委托加工合作框架协议的公告,/disclosure/listedinfo/announcement/c/2017-05-05/603456_20170505_1.pdf
323,2017-05-06,九洲药业关于召开2016年年度股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2017-05-06/603456_20170506_1.pdf
324,2017-05-10,九洲药业：中信证券股份有限公司关于浙江九洲药业股份有限公司2015年度非公开发行股票之持续督导保荐总结报告书,/disclosure/listedinfo/announcement/c/2017-05-10/603456_20170510_1.pdf
325,2017-05-16,九洲药业2016年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-05-16/603456_20170516_1.pdf
326,2017-05-16,九洲药业2016年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2017-05-16/603456_20170516_2.pdf
327,2017-05-17,九洲药业第五届董事会第二十二次会议决议公告,/disclosure/listedinfo/announcement/c/2017-05-17/603456_20170517_1.pdf
328,2017-05-31,九洲药业关于召开2017年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2017-05-31/603456_20170531_9.pdf
329,2017-05-31,九洲药业独立董事关于公司2017年限制性股票激励计划（草案）及相关事项的独立意见,/disclosure/listedinfo/announcement/c/2017-05-31/603456_20170531_2.pdf
330,2017-05-31,九洲药业独立董事公开征集委托投票权报告书,/disclosure/listedinfo/announcement/c/2017-05-31/603456_20170531_10.pdf
331,2017-05-31,九洲药业第五届监事会第十六次会议决议公告,/disclosure/listedinfo/announcement/c/2017-05-31/603456_20170531_8.pdf
332,2017-05-31,九洲药业第五届董事会第二十三次会议决议公告,/disclosure/listedinfo/announcement/c/2017-05-31/603456_20170531_7.pdf
333,2017-05-31,九洲药业：浙江天册律师事务所关于浙江九洲药业股份有限公司2017年限制性股票激励计划的法律意见书,/disclosure/listedinfo/announcement/c/2017-05-31/603456_20170531_3.pdf
334,2017-05-31,九洲药业2017年限制性股票激励计划实施考核管理办法,/disclosure/listedinfo/announcement/c/2017-05-31/603456_20170531_4.pdf
335,2017-05-31,九洲药业2017年限制性股票激励计划激励对象名单,/disclosure/listedinfo/announcement/c/2017-05-31/603456_20170531_6.pdf
336,2017-05-31,九洲药业2017年限制性股票激励计划（草案）摘要,/disclosure/listedinfo/announcement/c/2017-05-31/603456_20170531_1.pdf
337,2017-05-31,九洲药业2017年限制性股票激励计划（草案）,/disclosure/listedinfo/announcement/c/2017-05-31/603456_20170531_5.pdf
338,2017-06-01,九洲药业2016年年度权益分派实施公告,/disclosure/listedinfo/announcement/c/2017-06-01/603456_20170601_1.pdf
339,2017-06-03,九洲药业关于完成法定代表人工商变更登记的公告,/disclosure/listedinfo/announcement/c/2017-06-03/603456_20170603_1.pdf
340,2017-06-03,九洲药业关于控股股东部分股权质押的公告,/disclosure/listedinfo/announcement/c/2017-06-03/603456_20170603_2.pdf
341,2017-06-06,九洲药业2017年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2017-06-06/603456_20170606_1.pdf
342,2017-06-13,九洲药业监事会关于公司2017年限制性股票激励对象名单的审核及公示情况说明,/disclosure/listedinfo/announcement/c/2017-06-13/603456_20170613_2.pdf
343,2017-06-13,九洲药业关于召开2017年第一次临时股东大会的提示性通知,/disclosure/listedinfo/announcement/c/2017-06-13/603456_20170613_1.pdf
344,2017-06-21,九洲药业关于2017年限制性股票激励计划内幕信息知情人买卖股票自查报告,/disclosure/listedinfo/announcement/c/2017-06-21/603456_20170621_3.pdf
345,2017-06-21,九洲药业2017年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-06-21/603456_20170621_1.pdf
346,2017-06-21,九洲药业2017年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2017-06-21/603456_20170621_2.pdf
347,2017-06-27,九洲药业关于更换保荐代表人的公告,/disclosure/listedinfo/announcement/c/2017-06-27/603456_20170627_1.pdf
348,2017-07-01,九洲药业监事会关于公司2017年限制性股票激励计划首次授予事项的核查意见,/disclosure/listedinfo/announcement/c/2017-07-01/603456_20170701_7.pdf
349,2017-07-01,九洲药业关于首次向激励对象授予限制性股票的公告,/disclosure/listedinfo/announcement/c/2017-07-01/603456_20170701_3.pdf
350,2017-07-01,九洲药业关于拟在香港投资设立全资子公司的公告,/disclosure/listedinfo/announcement/c/2017-07-01/603456_20170701_9.pdf
351,2017-07-01,九洲药业关于调整公司2017年限制性股票激励计划相关事项的公告,/disclosure/listedinfo/announcement/c/2017-07-01/603456_20170701_8.pdf
352,2017-07-01,九洲药业独立董事关于公司2017年限制性股票激励计划调整及首次授予事项的独立意见,/disclosure/listedinfo/announcement/c/2017-07-01/603456_20170701_4.pdf
353,2017-07-01,九洲药业第五届监事会第十七次会议决议公告,/disclosure/listedinfo/announcement/c/2017-07-01/603456_20170701_2.pdf
354,2017-07-01,九洲药业第五届董事会第二十四次会议决议公告,/disclosure/listedinfo/announcement/c/2017-07-01/603456_20170701_1.pdf
355,2017-07-01,九洲药业：浙江天册律师事务所关于浙江九洲药业股份有限公司2017年限制性股票激励计划相关事项调整及首次授予的法律意见书,/disclosure/listedinfo/announcement/c/2017-07-01/603456_20170701_5.pdf
356,2017-07-01,九洲药业2017年限制性股票激励计划首次授予激励对象名单,/disclosure/listedinfo/announcement/c/2017-07-01/603456_20170701_6.pdf
357,2017-07-19,九洲药业2017年半年度业绩预增公告,/disclosure/listedinfo/announcement/c/2017-07-19/603456_20170719_1.pdf
358,2017-08-04,九洲药业关于公司2017年限制性股票授予结果的公告,/disclosure/listedinfo/announcement/c/2017-08-04/603456_20170804_1.pdf
359,2017-08-05,九洲药业：验资报告,/disclosure/listedinfo/announcement/c/2017-08-05/603456_20170805_1.pdf
360,2017-08-16,九洲药业关于修改《公司章程》的公告,/disclosure/listedinfo/announcement/c/2017-08-16/603456_20170816_5.pdf
361,2017-08-16,九洲药业关于公司会计政策变更的公告,/disclosure/listedinfo/announcement/c/2017-08-16/603456_20170816_7.pdf
362,2017-08-16,九洲药业关于公司2017年半年度募集资金存放与使用情况的专项报告,/disclosure/listedinfo/announcement/c/2017-08-16/603456_20170816_8.pdf
363,2017-08-16,九洲药业公司章程,/disclosure/listedinfo/announcement/c/2017-08-16/603456_20170816_6.pdf
364,2017-08-16,九洲药业第五届监事会第十八次会议决议公告,/disclosure/listedinfo/announcement/c/2017-08-16/603456_20170816_4.pdf
365,2017-08-16,九洲药业第五届董事会第二十五次会议决议公告,/disclosure/listedinfo/announcement/c/2017-08-16/603456_20170816_3.pdf
366,2017-08-16,九洲药业2017年半年度报告摘要,/disclosure/listedinfo/announcement/c/2017-08-16/603456_2017_zzy.pdf
367,2017-08-16,九洲药业2017年半年度报告,/disclosure/listedinfo/announcement/c/2017-08-16/603456_2017_z.pdf
368,2017-08-24,九洲药业关于投资者交流会召开情况的公告,/disclosure/listedinfo/announcement/c/2017-08-24/603456_20170824_1.pdf
369,2017-09-09,九洲药业关于设立香港子公司的进展公告,/disclosure/listedinfo/announcement/c/2017-09-09/603456_20170909_1.pdf
370,2017-09-26,九洲药业关于2017年限制性股票授予完成工商变更登记的公告,/disclosure/listedinfo/announcement/c/2017-09-26/603456_20170926_1.pdf
371,2017-09-27,九洲药业首次公开发行限售股上市流通公告,/disclosure/listedinfo/announcement/c/2017-09-27/603456_20170927_1.pdf
372,2017-09-27,九洲药业：中信证券股份有限公司关于浙江九洲药业股份有限公司首次公开发行限售股上市流通的核查意见,/disclosure/listedinfo/announcement/c/2017-09-27/603456_20170927_2.pdf
373,2017-10-26,九洲药业关于注销全资子公司的公告,/disclosure/listedinfo/announcement/c/2017-10-26/603456_20171026_10.pdf
374,2017-10-26,九洲药业关于召开2017年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2017-10-26/603456_20171026_11.pdf
375,2017-10-26,九洲药业独立董事提名人声明,/disclosure/listedinfo/announcement/c/2017-10-26/603456_20171026_8.pdf
376,2017-10-26,九洲药业独立董事候选人声明（杨立荣）,/disclosure/listedinfo/announcement/c/2017-10-26/603456_20171026_5.pdf
377,2017-10-26,九洲药业独立董事候选人声明（潘杰）,/disclosure/listedinfo/announcement/c/2017-10-26/603456_20171026_6.pdf
378,2017-10-26,九洲药业独立董事候选人声明（孔德兰）,/disclosure/listedinfo/announcement/c/2017-10-26/603456_20171026_7.pdf
379,2017-10-26,九洲药业独立董事关于第五届董事会第二十六次会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2017-10-26/603456_20171026_4.pdf
380,2017-10-26,九洲药业第五届监事会第十九次会议决议公告,/disclosure/listedinfo/announcement/c/2017-10-26/603456_20171026_9.pdf
381,2017-10-26,九洲药业第五届董事会第二十六次会议决议公告,/disclosure/listedinfo/announcement/c/2017-10-26/603456_20171026_3.pdf
382,2017-10-26,九洲药业2017年第三季度报告,/disclosure/listedinfo/announcement/c/2017-10-26/603456_2017_3.pdf
383,2017-11-08,九洲药业2017年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2017-11-08/603456_20171108_1.pdf
384,2017-11-10,九洲药业关于2017年第二次临时股东大会通知的更正公告,/disclosure/listedinfo/announcement/c/2017-11-10/603456_20171110_1.pdf
385,2017-11-14,九洲药业关于召开2017年第二次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2017-11-14/603456_20171114_2.pdf
386,2017-11-14,九洲药业关于公司股东协议转让股份的计划公告,/disclosure/listedinfo/announcement/c/2017-11-14/603456_20171114_1.pdf
387,2017-11-18,九洲药业关于部分募集资金专户销户的公告,/disclosure/listedinfo/announcement/c/2017-11-18/603456_20171118_6.pdf
388,2017-11-18,九洲药业独立董事关于第六届董事会第一次会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2017-11-18/603456_20171118_4.pdf
389,2017-11-18,九洲药业第六届监事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2017-11-18/603456_20171118_5.pdf
390,2017-11-18,九洲药业第六届董事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2017-11-18/603456_20171118_3.pdf
391,2017-11-18,九洲药业2017年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-11-18/603456_20171118_1.pdf
392,2017-11-18,九洲药业2017年第二次临时股东大会法律意见书,/disclosure/listedinfo/announcement/c/2017-11-18/603456_20171118_2.pdf
393,2017-11-21,九洲药业简式权益变动报告书（中贝集团、台州歌德）,/disclosure/listedinfo/announcement/c/2017-11-21/603456_20171121_6.pdf
394,2017-11-21,九洲药业简式权益变动报告书（罗月芳）,/disclosure/listedinfo/announcement/c/2017-11-21/603456_20171121_7.pdf
395,2017-11-21,九洲药业关于职工监事换届履职的公告,/disclosure/listedinfo/announcement/c/2017-11-21/603456_20171121_8.pdf
396,2017-11-21,九洲药业关于股东协议转让股份的提示性公告,/disclosure/listedinfo/announcement/c/2017-11-21/603456_20171121_5.pdf
397,2017-12-05,九洲药业2017年度业绩预增公告,/disclosure/listedinfo/announcement/c/2017-12-05/603456_20171205_1.pdf
398,2017-12-06,九洲药业关于公司临海分公司完成注销登记的公告,/disclosure/listedinfo/announcement/c/2017-12-06/603456_20171206_1.pdf
399,2017-12-23,九洲药业关于公司通过高新技术企业重新认定的公告,/disclosure/listedinfo/announcement/c/2017-12-23/603456_20171223_1.pdf
400,2018-01-09,九洲药业关于控股股东协议转让部分公司股份完成过户登记的公告,/disclosure/listedinfo/announcement/c/2018-01-09/603456_20180109_1.pdf
401,2018-01-20,九洲药业关于拟投资设立医药产业并购基金的公告,/disclosure/listedinfo/announcement/c/2018-01-20/603456_20180120_2.pdf
402,2018-01-20,九洲药业2017年度业绩预增公告,/disclosure/listedinfo/announcement/c/2018-01-20/603456_20180120_1.pdf
403,2018-01-22,九洲药业关于董事会审议控股股东提议高送转预案的公告,/disclosure/listedinfo/announcement/c/2018-01-22/603456_20180122_1.pdf
404,2018-01-22,九洲药业独立董事关于控股股东提议高送转预案的独立意见,/disclosure/listedinfo/announcement/c/2018-01-22/603456_20180122_2.pdf
405,2018-01-22,九洲药业独立董事关于控股股东提议高送转预案的独立意见,/disclosure/listedinfo/announcement/c/2018-01-22/603456_20180122_4.pdf
406,2018-01-22,九洲药业第六届董事会第三次会议决议公告,/disclosure/listedinfo/announcement/c/2018-01-22/603456_20180122_3.pdf
407,2018-01-23,九洲药业关于收到上海证券交易所高送转事项问询函暨公司股票停牌的公告,/disclosure/listedinfo/announcement/c/2018-01-23/603456_20180123_1.pdf
408,2018-01-24,九洲药业关于上海证券交易所高送转预案事项问询函的回复及复牌公告,/disclosure/listedinfo/announcement/c/2018-01-24/603456_20180124_1.pdf
409,2018-01-25,九洲药业关于控股股东提议的高送转预案之风险提示公告,/disclosure/listedinfo/announcement/c/2018-01-25/603456_20180125_2.pdf
410,2018-02-06,九洲药业关于控股股东股权解除质押暨质押的公告,/disclosure/listedinfo/announcement/c/2018-02-06/603456_20180206_1.pdf
411,2018-02-06,九洲药业关于股东部分股份质押解除的公告,/disclosure/listedinfo/announcement/c/2018-02-06/603456_20180206_2.pdf
412,2018-02-14,九洲药业未来三年（2018—2020年）股东分红回报规划,/disclosure/listedinfo/announcement/c/2018-02-14/603456_20180214_25.pdf
413,2018-02-14,九洲药业关于召开2017年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2018-02-14/603456_20180214_29.pdf
414,2018-02-14,九洲药业关于续聘天健会计师事务所（特殊普通合伙）为公司2018年度财务、内控审计机构的公告,/disclosure/listedinfo/announcement/c/2018-02-14/603456_20180214_15.pdf
415,2018-02-14,九洲药业关于使用闲置自有资金开展理财业务的公告,/disclosure/listedinfo/announcement/c/2018-02-14/603456_20180214_24.pdf
416,2018-02-14,九洲药业关于控股股东为公司全资子公司2018年度申请银行授信提供担保暨关联交易的公告,/disclosure/listedinfo/announcement/c/2018-02-14/603456_20180214_18.pdf
417,2018-02-14,九洲药业关于公司以自有资产申请银行授信的公告,/disclosure/listedinfo/announcement/c/2018-02-14/603456_20180214_17.pdf
418,2018-02-14,九洲药业关于公司2018年度向浙江四维医药科技有限公司增资的公告,/disclosure/listedinfo/announcement/c/2018-02-14/603456_20180214_21.pdf
419,2018-02-14,九洲药业关于公司2018年度向江苏瑞科医药科技有限公司提供借款和担保额度的公告,/disclosure/listedinfo/announcement/c/2018-02-14/603456_20180214_20.pdf
420,2018-02-14,九洲药业关于公司2018年度开展远期结售汇业务的公告,/disclosure/listedinfo/announcement/c/2018-02-14/603456_20180214_16.pdf
421,2018-02-14,九洲药业关于公司2017年度募集资金存放与使用情况的专项报告,/disclosure/listedinfo/announcement/c/2018-02-14/603456_20180214_12.pdf
422,2018-02-14,九洲药业关于公司2017年度募集资金存放与使用情况的专项报告,/disclosure/listedinfo/announcement/c/2018-02-14/603456_20180214_7.pdf
423,2018-02-14,九洲药业关于变更部分募集资金投资项目实施地点的公告,/disclosure/listedinfo/announcement/c/2018-02-14/603456_20180214_22.pdf
424,2018-02-14,九洲药业独立董事关于第六届董事会第四次会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2018-02-14/603456_20180214_3.pdf
425,2018-02-14,九洲药业独立董事关于第六届董事会第四次会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2018-02-14/603456_20180214_19.pdf
426,2018-02-14,九洲药业独立董事2017年度述职报告,/disclosure/listedinfo/announcement/c/2018-02-14/603456_20180214_30.pdf
427,2018-02-14,九洲药业董事、监事和高级管理人员薪酬管理制度,/disclosure/listedinfo/announcement/c/2018-02-14/603456_20180214_27.pdf
428,2018-02-14,九洲药业第五届董事会审计委员会2017年度履职报告,/disclosure/listedinfo/announcement/c/2018-02-14/603456_20180214_11.pdf
429,2018-02-14,九洲药业第五届董事会审计委员会2017年度履职报告,/disclosure/listedinfo/announcement/c/2018-02-14/603456_20180214_6.pdf
430,2018-02-14,九洲药业第六届监事会第二次会议决议公告,/disclosure/listedinfo/announcement/c/2018-02-14/603456_20180214_28.pdf
431,2018-02-14,九洲药业第六届董事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2018-02-14/603456_20180214_26.pdf
432,2018-02-14,九洲药业：中信证券股份有限公司关于浙江九洲药业股份有限公司变更部分募集资金投资项目实施地点的核查意见,/disclosure/listedinfo/announcement/c/2018-02-14/603456_20180214_23.pdf
433,2018-02-14,九洲药业：中信证券股份有限公司关于浙江九洲药业股份有限公司2017年度募集资金存放与使用情况的专项核查报告,/disclosure/listedinfo/announcement/c/2018-02-14/603456_20180214_10.pdf
434,2018-02-14,九洲药业：中信证券股份有限公司关于浙江九洲药业股份有限公司2017年度募集资金存放与使用情况的专项核查报告,/disclosure/listedinfo/announcement/c/2018-02-14/603456_20180214_14.pdf
435,2018-02-14,九洲药业：内部控制审计报告,/disclosure/listedinfo/announcement/c/2018-02-14/603456_20180214_9.pdf
436,2018-02-14,九洲药业：募集资金年度存放与使用情况鉴证报告,/disclosure/listedinfo/announcement/c/2018-02-14/603456_20180214_8.pdf
437,2018-02-14,九洲药业：募集资金年度存放与使用情况鉴证报告,/disclosure/listedinfo/announcement/c/2018-02-14/603456_20180214_13.pdf
438,2018-02-14,九洲药业：会计师关于公司控股股东及关联方非经营性资金占用的专项报告,/disclosure/listedinfo/announcement/c/2018-02-14/603456_20180214_5.pdf
439,2018-02-14,九洲药业：财务审计报告,/disclosure/listedinfo/announcement/c/2018-02-14/603456_20180214_4.pdf
440,2018-02-14,九洲药业2017年年度报告摘要,/disclosure/listedinfo/announcement/c/2018-02-14/603456_2017_nzy.pdf
441,2018-02-14,九洲药业2017年年度报告,/disclosure/listedinfo/announcement/c/2018-02-14/603456_2017_n.pdf
442,2018-02-15,九洲药业关于2017年年度报告的更正公告,/disclosure/listedinfo/announcement/c/2018-02-15/603456_20180215_3.pdf
443,2018-02-15,九洲药业独立董事关于控股股东为公司全资子公司2018年度申请银行授信提供担保暨关联交易的事前认可函,/disclosure/listedinfo/announcement/c/2018-02-15/603456_20180215_2.pdf
444,2018-02-15,九洲药业：江苏瑞科医药科技有限公司2017年度财务报表,/disclosure/listedinfo/announcement/c/2018-02-15/603456_20180215_1.pdf
445,2018-02-15,九洲药业2017年年度报告摘要（修订版）,/disclosure/listedinfo/announcement/c/2018-02-15/603456_2017_nzyA.pdf
446,2018-02-15,九洲药业2017年年度报告（修订版）,/disclosure/listedinfo/announcement/c/2018-02-15/603456_2017_nA.pdf
